These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 721787)

  • 1. Haloperidol and thiothixene in the long-term treatment of chronic schizophrenic outpatients in an urban community: social and vocational adjustment.
    Engelhardt DM; Rudorfer L; Rosen B
    J Clin Psychiatry; 1978 Dec; 39(12):834-40. PubMed ID: 721787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol and thiothixene in the long-term treatment of chronic schizophrenic outpatients in an urban community: social and vocational adjustment.
    Slotnick VB
    J Clin Psychiatry; 1980 Mar; 41(3):105-6. PubMed ID: 7354016
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
    Abuzzahab FS; Zimmerman RL
    J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative efficacy of parenteral haloperidol and thiothixene for the emergency treatment of acutely excited and agitated patients.
    Stotsky BA
    Dis Nerv Syst; 1977 Dec; 38(12):967-73. PubMed ID: 338270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia.
    Knight RG; Harrison A
    N Z Med J; 1979 Apr; 89(634):302-4. PubMed ID: 377155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of efficacy of zotepine and thiothixene in schizophrenia in a double-blind study.
    Sarai K; Okada M
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):38-46. PubMed ID: 2883680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of thiothixene on schizophrenic symptoms in a long-term therapeutic scheme. Comparative study with butyrophenone derivative].
    Vianna Filho U; Muniz AF; Terra SO; Bueno JR
    J Bras Psiquiatr; 1971; 20(3):193-204. PubMed ID: 5164436
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid tranquilization: a comparative study of thiothixene and haloperidol.
    Kelwala S; Ban TA; Berney SA; Wilson WH
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):77-83. PubMed ID: 6145189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of loxapine succinate in the treatment of schizophrenia: a comparative study with thiothixene.
    Vianna Filho U; Versiani Caldeira V; Romildo Bueno J
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):476-90. PubMed ID: 810308
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid tranquilization: a comparison of thiothixene with loxapine.
    Dubin WR; Weiss KJ
    J Clin Psychiatry; 1986 Jun; 47(6):294-7. PubMed ID: 3711026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The assessment of thiothixene in chronic schizophrenia. A double-blind controlled trial.
    Burnett GB; Little SR; Graham N; Forrest AD
    Dis Nerv Syst; 1975 Nov; 36(11):625-9. PubMed ID: 1102277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haloperidol for chronically hospitalized psychotics: a double-blind comparison with thiothixene and placebo; a follow-up open evaluation.
    Howard JS
    Dis Nerv Syst; 1974 Oct; 35(10):458-63. PubMed ID: 17894059
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of phenothiazine and nonphenothiazine neuroleptics according to psychopathology, side effects and computerized EEG.
    Itil TM; Patterson CD; Keskiner A; Holden JM
    Adv Biochem Psychopharmacol; 1974; 9(0):499-509. PubMed ID: 4599437
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G; Annable L; Campbell W
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High and low dose thiothixene treatment in chronic schizophrenia.
    Gardos G; Orzack MH; Finn G; Cole JO
    Dis Nerv Syst; 1974 Feb; 35(2):53-8. PubMed ID: 17894041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol.
    Serban G; Siegel S
    Am J Psychiatry; 1984 Nov; 141(11):1455-8. PubMed ID: 6388363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Speed and rate of remission in acute schizophrenia: a comparison of intramuscularly administered fluphenazine HC1 with thiothixene and haloperidol.
    Levenson AJ; Burnett GB; Nottingham JD; Sermas CE; Thornby JI
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):695-700. PubMed ID: 825356
    [No Abstract]   [Full Text] [Related]  

  • 18. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
    Wilson LG; Roberts RW; Gerber CJ; Johnson MH
    J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computerized EEG: predictor of outcome in schizophrenia.
    Itil TM; Marasa J; Saletu B; Davis S; Mucciardi AN
    J Nerv Ment Dis; 1975 Mar; 160(3):118-203. PubMed ID: 1090708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
    Akhondzadeh S; Safarcherati A; Amini H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.